| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8940770 | European Urology Oncology | 2018 | 8 Pages |
Abstract
We assessed oncological and functional outcomes associated with cytoreductive radical prostatectomy (CRP) in select men with prostate cancer and osseous metastases. We found that CRP might be associated with long overall and relapse-free survival in well-selected patients. CRP could become an additional treatment option in the multimodal therapy of metastatic prostate cancer; it should be performed in a clinical protocol setting and does not represent a standard therapeutic option.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi, Francesco Montorsi, Shahrokh Shariat, Bernhard Grubmüller, Giorgio Gandaglia, Alberto Briganti, R. Jeffrey Karnes,